14th May 2020: The cardiovascular ultrasound (CVUS) market is likely to witness growth due to increasing prevalence of cardiovascular disease and rise in penetration of preventive medicine across the globe. Cardiology is a study that involves structures of heart and their functions in medicine. Major function of heart is blood circulation and carrying oxygen through blood. Noninvasive ultrasound technology is used by cardiologists, vascular surgeons, and internal medicine providers for imaging to diagnose and analyze function of the heart.
Echocardiography Enables Detection of Heart Abnormalities before Birth
Based on type, the market is segmented into transesophageal echocardiography, transthoracic echocardiography, and fetal echocardiography. The fetal echocardiography segment is likely to witness the fastest growth over the forecast period.
In order to check all the four chambers of the heart and to track the development, fetal echocardiogram is used in the second trimester of the pregnancy tests. It enables visualization of the structure of the heart of the unborn child. Fetal health monitoring and increased awareness regarding the same has resulted in the surge in demand for cardiovascular ultrasound.
Transesophageal echocardiography is used when other procedures are unable to provide results. Increase in incidences of cardiovascular diseases (CVDs), technological advancements, and advantages of echocardiography over other imaging technologies are the factors responsible for growth of the segment. Cardiovascular ultrasound is highly noninvasive, reducing the duration of hospital stay, which is further fueling the growth of the market.
Market Insights
The growth of the cardiovascular ultrasound industry is due to the benefits provided by the technology such as rapid results and quality images of heart conditions. Increasing R&D activities, rising investment in healthcare and meditech industry, and high prevalence of cardiovascular diseases are the key factors driving growth of the cardiovascular ultrasound industry. Technological advancements in heart related conditions such as lateral gain control, tissue enhancements, tissue Doppler, advanced dynamic flow, and stress echo provides varied growth opportunities for the market players.
Major companies of the cardiovascular ultrasound industry such as Philips Healthcare and Siemens Healthcare have B/W devices, which help to shift to the color mode of the ultrasound imaging to provide clarity and better diagnostic. For instance, Hitachi provides these color systems that are available in many countries around the world.
Some of the leading companies of the cardiovascular ultrasound market include Siemens Healthcare; GE Healthcare, Inc.; Hitachi; Philips; Canon Medical Systems Corporation; and Fujifilm Medical Systems.
No comments:
Post a Comment